Filter by: patients
Home > Community Treatment Reports and Side Effects > Levetiracetam Treatment Report
What is Levetiracetam?

Levetiracetam is is an anticonvulsant used in combination with other medications to treat partial onset, myoclonic, and/or primary generalized tonic-clonic seizures.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Epilepsy 700 284 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Seizures 55 11 Efficacy_major Efficacy_moderate Efficacy_none Efficacy_cant_tell
Seizures (grand mal or tonic-clonic) 42 23 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Seizures (complex partial) 36 17 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none
Other 30 4 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_cant_tell
Seizures (partial focal) 17 3 Efficacy_moderate Efficacy_slight Efficacy_cant_tell

See all 869 patients currently taking Levetiracetam

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 64
Moderate
 112
Mild
 105
None
 74

Commonly reported side effects, conditions, and hospitalizations associated with Levetiracetam

Fatigue 31
Sleepiness 20
Excessive daytime sleepiness (somnolence) 17
Memory problems 16
Dizziness 15
Depressed mood 14
See all 201 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Levetiracetam. See all 65 dosages ►

  250 mg daily 500 mg daily 750 mg daily 1,000 mg daily 1,500 mg daily 2,000 mg daily 2,250 mg daily 2,500 mg daily 3,000 mg daily 4,000 mg daily
  18 Number of Patients: 18 94 Number of Patients: 94 20 Number of Patients: 20 189 Number of Patients: 189 113 Number of Patients: 113 140 Number of Patients: 140 14 Number of Patients: 14 34 Number of Patients: 34 161 Number of Patients: 161 34 Number of Patients: 34  

Reported Stop Reasons

Why Patients Stopped Taking Levetiracetam (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 102   Side effects too severe: 48%
Did not seem to work 70   Did not seem to work: 33%
Doctor's advice 59   Doctor's advice: 28%
Other 24   Other: 11%
Expense 17   Expense: 8%
Course of treatment ended 11   Course of treatment ended: 5%
Personal research 8   Personal research: 4%
Not indicated 6   Not indicated: 3%
Change in health plan coverage 4   Change in health plan coverage: 2%

See all 204 patients who’ve stopped taking Levetiracetam

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Levetiracetam

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Levetiracetam

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Levetiracetam

Always
 315 89%
Usually
 30 8%
Sometimes
 3 1%
Never
 7 2%

Burden

Difficulty being on treatment

Burden of Levetiracetam

Very
 23 6%
Somewhat
 34 10%
A little
 58 16%
Not at all
 240 68%

Cost

Paid out of pocket

Cost of Levetiracetam

$200+
 15 7%
$100-199
 12 5%
$50-99
 33 14%
$25-49
 27 12%
< $25
 140 61%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.